These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 15274325)
21. The X-chromosome Gomez-Esquer F; Agudo D; Martinez-Arribas F; Nunez-Villar MJ; Pollan M; Schneider J Cancer Genomics Proteomics; 2004; 1(1):39-44. PubMed ID: 31394616 [TBL] [Abstract][Full Text] [Related]
22. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype. Núñez-Villar MJ; Martínez-Arribas F; Pollán M; Lucas AR; Sánchez J; Tejerina A; Schneider J Breast Cancer Res; 2003; 5(3):R65-70. PubMed ID: 12793902 [TBL] [Abstract][Full Text] [Related]
23. High expression of CD105 as a prognostic predictor of early tongue cancer. Chuang HC; Su CY; Huang HY; Chien CY; Chen CM; Huang CC Laryngoscope; 2006 Jul; 116(7):1175-9. PubMed ID: 16826056 [TBL] [Abstract][Full Text] [Related]
24. Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage. Schmidt M; Voelker HU; Kapp M; Dietl J; Kammerer U Anticancer Res; 2008; 28(3A):1719-24. PubMed ID: 18630531 [TBL] [Abstract][Full Text] [Related]
25. Role of tumor suppressor and angiogenesis markers in prediction of recurrence of non muscle invasive bladder cancer. Agrawal U; Mishra AK; Salgia P; Verma S; Mohanty NK; Saxena S Pathol Oncol Res; 2011 Mar; 17(1):91-101. PubMed ID: 20571940 [TBL] [Abstract][Full Text] [Related]
28. The small variant of the apoptosis-associated X-chromosome RBM10 gene is co-expressed with caspase-3 in breast cancer. Martín-Garabato E; Martínez-Arribas F; Pollán M; Lucas AR; Sánchez J; Schneider J Cancer Genomics Proteomics; 2008; 5(3-4):169-73. PubMed ID: 18820371 [TBL] [Abstract][Full Text] [Related]
29. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Agudo D; Gómez-Esquer F; Martínez-Arribas F; Núñez-Villar MJ; Pollán M; Schneider J Int J Cancer; 2004 May; 109(5):717-20. PubMed ID: 14999780 [TBL] [Abstract][Full Text] [Related]
30. Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors. Adam M; Schmidt D; Wardelmann E; Wernert N; Albers P Eur Urol; 2003 Sep; 44(3):329-36. PubMed ID: 12932931 [TBL] [Abstract][Full Text] [Related]
31. The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Takenaka K; Katakura H; Chen F; Ogawa E; Adachi M; Wada H; Tanaka F Cancer Lett; 2007 Feb; 246(1-2):34-40. PubMed ID: 16530326 [TBL] [Abstract][Full Text] [Related]
32. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers]. Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873 [TBL] [Abstract][Full Text] [Related]
33. [Study of mRNA expression of vascular endothelial growth factor-(A, C, D) genes and its effect on prognosis of breast cancer]. Zhang GH; Zeng Y; Yang WT; Shi DR Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):473-7. PubMed ID: 17069700 [TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components. Yamasaki T; Tsuda H; Imazeki N; Matsubara O Pathol Int; 2005 May; 55(5):255-63. PubMed ID: 15871723 [TBL] [Abstract][Full Text] [Related]
35. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Taranger-Charpin C Br J Cancer; 2004 Mar; 90(6):1216-21. PubMed ID: 15026804 [TBL] [Abstract][Full Text] [Related]
36. Bax expression in untreated breast cancer: an immunocytometric study of 255 cases. Martínez-Arribas F; Martín-Garabato E; Zapardiel I; Sánchez J; Lucas AR; Tejerina A; Schneider J Anticancer Res; 2008; 28(5A):2595-8. PubMed ID: 19035283 [TBL] [Abstract][Full Text] [Related]
37. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma. Raica M; Cimpean AM; Anghel A Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316 [TBL] [Abstract][Full Text] [Related]
39. CD105 expression is an independent predictor of survival in patients with endometrial cancer. Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456 [TBL] [Abstract][Full Text] [Related]
40. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer]. Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]